This mechanism has indeed been observed in an in vivo mouse model of the basal-type breast cancer, in which α3β1 promotes proliferation and survival of tumor cells through activation of the FAK-PAK1-ERK1/2 signaling pathway [18]. The gene discussed is MAPK3; the disease is breast carcinoma.